David J SullivanJr
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
David J SullivanJr has a total of 121 co-authors. Here are the top co-authors by number of shared publications:
- Wasif Ali Khan
International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B), Dhaka, Bangladesh
7 shared publications Lirong Shi
6 shared publications- Mohammad Shafiul Alam
Infectious Diseases Division Dhaka International Centre for Diarrheal Diseases Research
5 shared publications - Rashidul Haque
International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B), Dhaka, Bangladesh
5 shared publications - David A. Sack
Department of International Health, Johns Hopkins University Bloomberg School of Public Health
4 shared publications - Gregory E. Glass
Department of Molecular Microbiology and Immunology, John Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
4 shared publications
Latest Publications
- 1 January 2025
- Published by Springer Nature
- p. 311-317
Emerging Diagnostic Platforms for Malaria
- 10 October 2014
- Published by Springer Nature
- p. 1-7
Emerging Diagnostic Platforms for Malaria
- 6 August 2014
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 91 (2) , 374-383
The Practice of Jhum Cultivation and its Relationship to Plasmodium falciparum Infection in the Chittagong Hill Districts of Bangladesh
Malaria is endemic in the Chittagong Hill Districts of southeastern Bangladesh. Previous epidemiological analyses identified the agricultural practice of jhum cultivation as a potential risk factor for malaria infection. We conducted qualitative interviews with jhum cultivators and surveillance workers to describe jhum cultivation and used demographic and malaria surveillance in two study unions from May of 2010 to August of 2012 to better understand the relationship between jhum cultivation and malaria infection. Qualitative interviews revealed that jhum cultivation is conducted on remote, steep hillsides by ethnic tribal groups. Quantitative analyses found that adult jhum cultivators and individuals who live in the same residence had significantly higher incidence rates of symptomatic Plasmodium falciparum infection compared with non-cultivators. These results confirm that jhum cultivation is an independent risk factor for malaria infection and underscore the need for malaria testing and treatment services to reach remote populations in the Chittagong Hill Districts.
- 6 August 2014
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 91 (2) , 374-383
The Practice of Jhum Cultivation and its Relationship to Plasmodium falciparum Infection in the Chittagong Hill Districts of Bangladesh
Malaria is endemic in the Chittagong Hill Districts of southeastern Bangladesh. Previous epidemiological analyses identified the agricultural practice of jhum cultivation as a potential risk factor for malaria infection. We conducted qualitative interviews with jhum cultivators and surveillance workers to describe jhum cultivation and used demographic and malaria surveillance in two study unions from May of 2010 to August of 2012 to better understand the relationship between jhum cultivation and malaria infection. Qualitative interviews revealed that jhum cultivation is conducted on remote, steep hillsides by ethnic tribal groups. Quantitative analyses found that adult jhum cultivators and individuals who live in the same residence had significantly higher incidence rates of symptomatic Plasmodium falciparum infection compared with non-cultivators. These results confirm that jhum cultivation is an independent risk factor for malaria infection and underscore the need for malaria testing and treatment services to reach remote populations in the Chittagong Hill Districts.
- 1 June 2014
- Published by Elsevier in Acta Tropica
- Vol. 134, 52-57
A new visually improved and sensitive loop mediated isothermal amplification (LAMP) for diagnosis of symptomatic falciparum malaria
- 1 June 2014
- Published by Elsevier in Acta Tropica
- Vol. 134, 52-57
A new visually improved and sensitive loop mediated isothermal amplification (LAMP) for diagnosis of symptomatic falciparum malaria
- Open Access
- 1 June 2014
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 20 (6) , 941-949
Short-Term Malaria Reduction by Single-Dose Azithromycin during Mass Drug Administration for Trachoma, Tanzania
Single-dose mass drug administration of azithromycin (AZT) is underway to eliminate trachoma worldwide. Studies in Ethiopia showed a reduction in all-cause childhood deaths after administration. To examine the effect of single-dose AZ MDA on prevalent malaria infections in a large prospective cohort of children and parents in Dodoma Province, Tanzania, we quantified the temporal prevalence of malaria parasitemia by real-time PCR for 6 months after single-dose AZT. In the first month after treatment but not in subsequent months, Plasmodium falciparum infections were reduced by 73% (95% CI 43%–89%) in treatment versus control villages and differences remained significant (p = 0.00497) in multivariate models with village-level random effects. Genetic sequencing of P. falciparum ribosomal L4 protein showed no mutations associated with AZT resistance. AZT mass drug administration caused a transient, 1-month antimalarial effect without selecting for P. falciparum ribosomal L4 resistance mutations in a region with a 10-year history of treating trachoma with this drug.
- 1 June 2014
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 20 (6) , 941-949
Open AccessShort-Term Malaria Reduction by Single-Dose Azithromycin during Mass Drug Administration for Trachoma, Tanzania
Single-dose mass drug administration of azithromycin (AZT) is underway to eliminate trachoma worldwide. Studies in Ethiopia showed a reduction in all-cause childhood deaths after administration. To examine the effect of single-dose AZ MDA on prevalent malaria infections in a large prospective cohort of children and parents in Dodoma Province, Tanzania, we quantified the temporal prevalence of malaria parasitemia by real-time PCR for 6 months after single-dose AZT. In the first month after treatment but not in subsequent months, Plasmodium falciparum infections were reduced by 73% (95% CI 43%–89%) in treatment versus control villages and differences remained significant (p = 0.00497) in multivariate models with village-level random effects. Genetic sequencing of P. falciparum ribosomal L4 protein showed no mutations associated with AZT resistance. AZT mass drug administration caused a transient, 1-month antimalarial effect without selecting for P. falciparum ribosomal L4 resistance mutations in a region with a 10-year history of treating trachoma with this drug.
- Open Access
- 31 May 2014
- Published by Springer Nature in BMC Research Notes
- Vol. 7 (1) , 327
Resolution of a fungal mycotic aneurysm after a contaminated steroid injection: a case report
In the past ten years there have been three separate outbreaks of fungal contaminated steroid injections from compounding pharmacies. The 2012 outbreak of central nervous system fungal infections associated with contaminated methylprednisolone produced by a United States compounding pharmacy has led to 750 infections (151 with meningitis and paraspinal infections and 325 cases with paraspinal infections without meningitis) and 64 deaths as of October 23, 2013. Exserohilum rostratum has been the predominant pathogen identified by culture, polymerase chain reaction or antibody tests. According to previous reports, cerebral involvement with phaeohyphomycosis has a high risk of morbidity and mortality.
- 31 May 2014
- Published by Springer Nature in BMC Research Notes
- Vol. 7 (1) , 327
Open AccessResolution of a fungal mycotic aneurysm after a contaminated steroid injection: a case report
In the past ten years there have been three separate outbreaks of fungal contaminated steroid injections from compounding pharmacies. The 2012 outbreak of central nervous system fungal infections associated with contaminated methylprednisolone produced by a United States compounding pharmacy has led to 750 infections (151 with meningitis and paraspinal infections and 325 cases with paraspinal infections without meningitis) and 64 deaths as of October 23, 2013. Exserohilum rostratum has been the predominant pathogen identified by culture, polymerase chain reaction or antibody tests. According to previous reports, cerebral involvement with phaeohyphomycosis has a high risk of morbidity and mortality.
- Open Access
- 1 February 2014
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 58 (2) , 820-827
Antimalarial Efficacy of Hydroxyethylapoquinine (SN-119) and Its Derivatives
Quinine and other cinchona-derived alkaloids, although recently supplanted by the artemisinins (ARTs), continue to be important for treatment of severe malaria. Quinine and quinidine have narrow therapeutic indices, and a safer quinine analog is desirable, particularly with the continued threat of antimalarial drug resistance. Hydroxyethylapoquinine (HEAQ), used at 8 g a day for dosing in humans in the 1930s and halving mortality from bacterial pneumonias, was shown to cure bird malaria in the 1940s and was also reported as treatment for human malaria cases. Here we describe synthesis of HEAQ and its novel stereoisomer hydroxyethylapoquinidine (HEAQD) along with two intermediates, hydroxyethylquinine (HEQ) and hydroxyethylquinidine (HEQD), and demonstrate comparable but elevated antimalarial 50% inhibitory concentrations (IC 50 ) of 100 to 200 nM against Plasmodium falciparum quinine-sensitive strain 3D7 (IC 50 , 56 nM). Only HEAQD demonstrated activity against quinine-tolerant P. falciparum strains Dd2 and INDO with IC 50 s of 300 to 700 nM. HEQD had activity only against Dd2 with an IC 50 of 313 nM. In the lethal mouse malaria model Plasmodium berghei ANKA, only HEQD had activity at 20 mg/kg of body weight comparable to that of the parent quinine or quinidine drugs measured by parasite inhibition and 30-day survival. In addition, HEQ, HEQD, and HEAQ (IC 50 ≥ 90 μM) have little to no human ether-à-go-go-related gene (hERG) channel inhibition expressed in CHO cells compared to HEAQD, quinine, and quinidine (hERG IC 50 s of 27, 42, and 4 μM, respectively). HEQD more closely resembled quinine in vitro and in vivo for Plasmodium inhibition and demonstrated little hERG channel inhibition, suggesting that further optimization and preclinical studies are warranted for this molecule.
- 1 February 2014
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 58 (2) , 820-827
Open AccessAntimalarial Efficacy of Hydroxyethylapoquinine (SN-119) and Its Derivatives
Quinine and other cinchona-derived alkaloids, although recently supplanted by the artemisinins (ARTs), continue to be important for treatment of severe malaria. Quinine and quinidine have narrow therapeutic indices, and a safer quinine analog is desirable, particularly with the continued threat of antimalarial drug resistance. Hydroxyethylapoquinine (HEAQ), used at 8 g a day for dosing in humans in the 1930s and halving mortality from bacterial pneumonias, was shown to cure bird malaria in the 1940s and was also reported as treatment for human malaria cases. Here we describe synthesis of HEAQ and its novel stereoisomer hydroxyethylapoquinidine (HEAQD) along with two intermediates, hydroxyethylquinine (HEQ) and hydroxyethylquinidine (HEQD), and demonstrate comparable but elevated antimalarial 50% inhibitory concentrations (IC 50 ) of 100 to 200 nM against Plasmodium falciparum quinine-sensitive strain 3D7 (IC 50 , 56 nM). Only HEAQD demonstrated activity against quinine-tolerant P. falciparum strains Dd2 and INDO with IC 50 s of 300 to 700 nM. HEQD had activity only against Dd2 with an IC 50 of 313 nM. In the lethal mouse malaria model Plasmodium berghei ANKA, only HEQD had activity at 20 mg/kg of body weight comparable to that of the parent quinine or quinidine drugs measured by parasite inhibition and 30-day survival. In addition, HEQ, HEQD, and HEAQ (IC 50 ≥ 90 μM) have little to no human ether-à-go-go-related gene (hERG) channel inhibition expressed in CHO cells compared to HEAQD, quinine, and quinidine (hERG IC 50 s of 27, 42, and 4 μM, respectively). HEQD more closely resembled quinine in vitro and in vivo for Plasmodium inhibition and demonstrated little hERG channel inhibition, suggesting that further optimization and preclinical studies are warranted for this molecule.
- Open Access
- 14 March 2013
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 110 (13) , 4866-4867
Timing is everything for artemisinin action
In Cambodia, the same region where chloroquine resistance developed in the 1950s, a significant delay in the Plasmodium falciparum parasite clearance rates to artemisinins has been persistently observed over the past 5 y, raising the specter of artemisinin “resistance” (1). The parasites in this region have imprints of genetic selection associated with the delay in parasite clearance rates measured by serial patient blood films (2⇓–4). However, the traditional continuous inhibition concentration 50% (IC50) drug assays measured directly with parasites from patient’s blood indicate no significant difference in IC50s (1, 5). In PNAS, Klonis et al. (6) expand upon our knowledge of intraerythrocytic action of artemisinins, in a tour de force of P. falciparum in vitro culture work, by exposing three laboratory isolates to short 1-, 2-, 4-, or 6-h pulses of artemisinins every hour throughout the 48-h life cycle to determine pulse drug IC50. An important unique finding is that an early ring stage that is less than 8-h-old is hypersensitive to artemisinins, and that intrinsic differences preexist among decades-old laboratory P. falciparum isolates not thought to be exposed to the artemisinin drugs before isolation. In an earlier report by Klonis et al. (7), as well as a report by ter Kuile et al. (8), the timing of artemisinin action had been demonstrated to coincide with the onset of hemoglobin ingestion during the late-ring or early trophozoite stages. This experimental window of artemisinin duration of action during the 48-h P. falciparum erythrocyte life cycle is longer than quinoline drugs, such as quinine, mefloquine, or lumefantrine, which inhibit heme crystallization (8). Many malariologists believe artemisinins work after iron activation to induce carbon-centered radical damage of nearby proteins for low 1- to 10-nM inhibition of Plasmodium trophozoite stages, … [↵][1]1E-mail: dsulliva{at}jhsph.edu. [1]: #xref-corresp-1-1
- 14 March 2013
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 110 (13) , 4866-4867
Open AccessTiming is everything for artemisinin action
In Cambodia, the same region where chloroquine resistance developed in the 1950s, a significant delay in the Plasmodium falciparum parasite clearance rates to artemisinins has been persistently observed over the past 5 y, raising the specter of artemisinin “resistance” (1). The parasites in this region have imprints of genetic selection associated with the delay in parasite clearance rates measured by serial patient blood films (2⇓–4). However, the traditional continuous inhibition concentration 50% (IC50) drug assays measured directly with parasites from patient’s blood indicate no significant difference in IC50s (1, 5). In PNAS, Klonis et al. (6) expand upon our knowledge of intraerythrocytic action of artemisinins, in a tour de force of P. falciparum in vitro culture work, by exposing three laboratory isolates to short 1-, 2-, 4-, or 6-h pulses of artemisinins every hour throughout the 48-h life cycle to determine pulse drug IC50. An important unique finding is that an early ring stage that is less than 8-h-old is hypersensitive to artemisinins, and that intrinsic differences preexist among decades-old laboratory P. falciparum isolates not thought to be exposed to the artemisinin drugs before isolation. In an earlier report by Klonis et al. (7), as well as a report by ter Kuile et al. (8), the timing of artemisinin action had been demonstrated to coincide with the onset of hemoglobin ingestion during the late-ring or early trophozoite stages. This experimental window of artemisinin duration of action during the 48-h P. falciparum erythrocyte life cycle is longer than quinoline drugs, such as quinine, mefloquine, or lumefantrine, which inhibit heme crystallization (8). Many malariologists believe artemisinins work after iron activation to induce carbon-centered radical damage of nearby proteins for low 1- to 10-nM inhibition of Plasmodium trophozoite stages, … [↵][1]1E-mail: dsulliva{at}jhsph.edu. [1]: #xref-corresp-1-1
- Open Access
- 4 February 2013
- Published by Springer Nature in Malaria Journal
- Vol. 12 (1) , 48
Mobile phones improve case detection and management of malaria in rural Bangladesh
The recent introduction of mobile phones into the rural Bandarban district of Bangladesh provided a resource to improve case detection and treatment of patients with malaria. During studies to define the epidemiology of malaria in villages in south-eastern Bangladesh, an area with hypoendemic malaria, the project recorded 986 mobile phone calls from families because of illness suspected to be malaria between June 2010 and June 2012. Based on phone calls, field workers visited the homes with ill persons, and collected blood samples for malaria on 1,046 people. 265 (25%) of the patients tested were positive for malaria. Of the 509 symptomatic malaria cases diagnosed during this study period, 265 (52%) were detected because of an initial mobile phone call. Mobile phone technology was found to be an efficient and effective method for rapidly detecting and treating patients with malaria in this remote area. This technology, when combined with local knowledge and field support, may be applicable to other hard-to-reach areas to improve malaria control.
- 4 February 2013
- Published by Springer Nature in Malaria Journal
- Vol. 12 (1) , 48
Open AccessMobile phones improve case detection and management of malaria in rural Bangladesh
The recent introduction of mobile phones into the rural Bandarban district of Bangladesh provided a resource to improve case detection and treatment of patients with malaria. During studies to define the epidemiology of malaria in villages in south-eastern Bangladesh, an area with hypoendemic malaria, the project recorded 986 mobile phone calls from families because of illness suspected to be malaria between June 2010 and June 2012. Based on phone calls, field workers visited the homes with ill persons, and collected blood samples for malaria on 1,046 people. 265 (25%) of the patients tested were positive for malaria. Of the 509 symptomatic malaria cases diagnosed during this study period, 265 (52%) were detected because of an initial mobile phone call. Mobile phone technology was found to be an efficient and effective method for rapidly detecting and treating patients with malaria in this remote area. This technology, when combined with local knowledge and field support, may be applicable to other hard-to-reach areas to improve malaria control.
- 1 January 2013
- Vol. 19 (2) , 282-9
Plasmodium drug targets outside the genetic control of the parasite.
Drug development often seeks to find "magic bullets" which target microbiologic proteins while not affecting host proteins. Paul Ehrlich tested methylene blue as an antimalarial but this dye was not superior to quinine. Many successful antimalarial therapies are "magic shotguns" which target many Plasmodium pathways with little interference in host metabolism. Two malaria drug classes, the 8- aminoquinolines and the artemisinins interact with cytochrome P450s and host iron protoporphyrin IX or iron, respectively, to generate toxic metabolites and/or radicals, which kill the parasite by interference with many proteins. The non 8-amino antimalarial quinolines like quinine or piperaquine bind heme to inhibit the process of heme crystallization, which results in multiple enzyme inhibition and membrane dysfunction. The quinolines and artemisinins are rapidly parasiticidal in contrast to metal chelators, which have a slower parasite clearance rate with higher drug concentrations. Iron chelators interfere with the artemisinins but otherwise represent a strategy of targeting multiple enzymes containing iron. Interest has been revived in antineoplastic drugs that target DNA metabolism as antimalarials. Specific drug targeting or investigation of the innate immunity directed to the more permeable trophozoite or schizont infected erythrocyte membrane has been under explored. Novel drug classes in the antimalarial development pipeline which either target multiple proteins or unchangeable cellular targets will slow the pace of drug resistance acquisition.
- 1 January 2013
- Vol. 19 (2) , 282-9
Plasmodium drug targets outside the genetic control of the parasite.
Drug development often seeks to find "magic bullets" which target microbiologic proteins while not affecting host proteins. Paul Ehrlich tested methylene blue as an antimalarial but this dye was not superior to quinine. Many successful antimalarial therapies are "magic shotguns" which target many Plasmodium pathways with little interference in host metabolism. Two malaria drug classes, the 8- aminoquinolines and the artemisinins interact with cytochrome P450s and host iron protoporphyrin IX or iron, respectively, to generate toxic metabolites and/or radicals, which kill the parasite by interference with many proteins. The non 8-amino antimalarial quinolines like quinine or piperaquine bind heme to inhibit the process of heme crystallization, which results in multiple enzyme inhibition and membrane dysfunction. The quinolines and artemisinins are rapidly parasiticidal in contrast to metal chelators, which have a slower parasite clearance rate with higher drug concentrations. Iron chelators interfere with the artemisinins but otherwise represent a strategy of targeting multiple enzymes containing iron. Interest has been revived in antineoplastic drugs that target DNA metabolism as antimalarials. Specific drug targeting or investigation of the innate immunity directed to the more permeable trophozoite or schizont infected erythrocyte membrane has been under explored. Novel drug classes in the antimalarial development pipeline which either target multiple proteins or unchangeable cellular targets will slow the pace of drug resistance acquisition.